Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
480.60
+1.60 (0.33%)
Jul 6, 2026, 12:43 PM CET
STO:SOBI Market Cap
STO:SOBI has a market cap or net worth of 165.66 billion as of July 6, 2026. Its market cap has increased by 69.39% in one year.
Market Cap
165.66B
Enterprise Value
183.79B
Revenue
28.96B
Ranking
n/a
PE Ratio
181.50
Stock Price
480.60
Market Cap Chart
Since September 15, 2006, STO:SOBI's market cap has increased from 4.83B to 165.66B, an increase of 3,331.06%. That is a compound annual growth rate of 19.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 165.66B | 44.43% |
| Dec 30, 2025 | 114.70B | 4.06% |
| Dec 30, 2024 | 110.22B | 20.19% |
| Dec 29, 2023 | 91.70B | 41.80% |
| Dec 30, 2022 | 64.67B | 16.86% |
| Dec 30, 2021 | 55.34B | 12.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.34B |
| Cereno Scientific AB | 1.63B |
| Orexo AB | 848.60M |
| Dicot Pharma AB | 783.92M |
| EQL Pharma AB | 683.61M |
| Nanexa AB | 662.46M |
| Enzymatica AB | 568.00M |
| Cinclus Pharma Holding AB | 510.05M |